Development of Next-Generation Prophylactic Antibodies for COVID-19

HSV2 vaccine development / Dr Seth Hetherington - Genocea Biosciencees - World VaccineПодробнее

TGH offers new Evusheld COVID-19 antibody treatmentПодробнее

GVN: Forefront of Virology Webinar Featuring Dr. Hideki HasegawaПодробнее

Human Challenge Trials: Supporting the development of ‘next generation’ COVID-19 VaccinesПодробнее

5/13/20 Coronavirus (COVID 19) Grand Rounds - Stanford Department of MedicineПодробнее

A Research and Development Roadmap for Broadly Protective Coronavirus VaccinesПодробнее

Development of a Vaccine and Monoclonal Antibodies for The Prevention and Treatment of COVID-19Подробнее

Monoclonal Antibodies for COVID-19 Illness and Prophylaxis: Update for Primary CareПодробнее

The Next Generation of Vaccines and Antiviral DrugsПодробнее

Next-Generation Monoclonal Antibodies for COVID-19: A Clinical UpdateПодробнее

Monoclonal Antibodies as COVID-19 Prophylaxis in Immunocompromised PatientsПодробнее

The Future of Vaccines, Variants, and Treatment: The Vital Role of COVID-19 Monoclonal AntibodiesПодробнее

Rino Rappuoli - COVID 19 VaccinesПодробнее

SARS-CoV-2 Vaccines Development: Monoclonal AntibodiesПодробнее

Monoclonal Antibodies - What you NEED to know!Подробнее

Can We Use Antibodies to Treat Covid-19?Подробнее

Monoclonal Antibodies for COVID-19: Who, When, and How?Подробнее

Monoclonal Antibody Therapy: COVID-19 TreatmentПодробнее

Latest Updates on Monoclonal Antibodies | Coronavirus in ContextПодробнее

WEBINAR | COVID-19 pre-exposure prophylaxis (prevention) with monoclonal antibodiesПодробнее

Accelerate COVID-19 Antibody Development via Single B Cell ScreeningПодробнее

COVID-19 Virtual Briefing Series Session 8: Monoclonal Antibody Therapy for COVID-19 Latino PatientsПодробнее